Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients-Reference-Cited by-同舟云学术

Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients

Published:2017-04-21 Issue:4 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Junqueira Daniela R¹,Zorzela Liliane M²,Perini Edson³

Affiliation:

1. Evidências em Saúde Publish Company (Brazil); The University of Sydney (Australia); Rua Santa Catarina 760 apto 601, Centro Belo Horizonte Minas Gerais (MG) Brazil 30170-080

2. University of Alberta; Department of Pediatrics; 8727-118 street Edmonton AB Canada T6G 1T4

3. Faculty of Pharmacy, Universidade Federal de Minas Gerais (UFMG); Centro de Estudos do Medicamento (Cemed), Department of Social Pharmacy; Av Antonia Carlos 6627-sala 1050-B2-Campus Pampulha Belo Horizonte Minas Gerais(MG) Brazil 31270-901

Publisher

Wiley

Subject

Pharmacology (medical)

Reference148 articles.

1. Greinacher A Randomized-double blind trial to assess the incidence and clinical relevance of heparin-induced thrombocytopenia (HIT) antibodies in trauma patients treated with unfractionated or low-molecular weight heparin, the HIT-TRAP trial clinicaltrials.gov/ct2/show/NCT00196417?term=nct00196417&rank=1

2. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia;Lubenow;Blood,2010

3. Anon PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) clinicaltrials.gov/ct2/show/NCT00182364?term=critical+limb&rank=42 2008

4. PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan;Cook;Journal of Critical Care,2011

5. Cook DJ PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) clinicaltrials.gov/ct/show/NCT00182143?order=1 2007

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis;Journal of Orthopaedics and Traumatology;2024-01-09

2. Biomedical applications of engineered heparin-based materials;Bioactive Materials;2024-01

3. Standard and Extended Thromboprophylaxis in Patients with Inflammatory Bowel Disease: A Literature Review;Euroasian journal of hepato-gastroenterology;2023-12-22

4. Standardization of Anti-Xa Assay and its Comparison with Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin Therapy;Indian Journal of Hematology and Blood Transfusion;2023-12-15

5. Cangrelor for cardiopulmonary bypass in delayed-onset heparin-induced thrombocytopenia: a case report;Research and Practice in Thrombosis and Haemostasis;2023-10